This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Jan 1;30(1):6-7.

doi: 10.1200/JCO.2011.37.5832. Epub 2011 Nov 28.

BEAM trial: lighting the way ahead?

PMID: 22124100
DOI: 10.1200/JCO.2011.37.5832

Editorial

BEAM trial: lighting the way ahead?

Adil I Daud. J Clin Oncol. 2012.

. 2012 Jan 1;30(1):6-7.

doi: 10.1200/JCO.2011.37.5832. Epub 2011 Nov 28.

Author

PMID: 22124100
DOI: 10.1200/JCO.2011.37.5832

No abstract available

PubMed Disclaimer

Comment on

BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.
Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson WE 3rd, O'Day SJ. Kim KB, et al. J Clin Oncol. 2012 Jan 1;30(1):34-41. doi: 10.1200/JCO.2011.34.6270. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124101 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information